These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38849369)

  • 1. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
    Widder S; Carmody LA; Opron K; Kalikin LM; Caverly LJ; LiPuma JJ
    Nat Commun; 2024 Jun; 15(1):4889. PubMed ID: 38849369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
    Widder S; Carmody L; Opron K; Kalikin L; Caverly L; LiPuma J
    Res Sq; 2024 Mar; ():. PubMed ID: 38562856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
    Widder S; Opron K; Carmody LA; Kalikin LM; Caverly LJ; LiPuma JJ
    bioRxiv; 2023 Jul; ():. PubMed ID: 37546739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
    Carmody LA; Kalikin LM; VanDevanter DR; Li G; Opron K; Simon RH; Caverly LJ; LiPuma JJ
    J Cyst Fibros; 2022 Sep; 21(5):766-768. PubMed ID: 35667975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability.
    Hampton TH; Thomas D; van der Gast C; O'Toole GA; Stanton BA
    Microbiol Spectr; 2021 Sep; 9(1):e0002921. PubMed ID: 34232099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung function and microbiota diversity in cystic fibrosis.
    Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
    Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.
    Skolnik K; Nguyen A; Somayaji R; Thornton CS; Waddell B; Surette MG; Rabin HR; Parkins MD
    BMC Pulm Med; 2015 Dec; 15():161. PubMed ID: 26651825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
    Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
    BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
    de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
    Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
    Carmody LA; Zhao J; Schloss PD; Petrosino JF; Murray S; Young VB; Li JZ; LiPuma JJ
    Ann Am Thorac Soc; 2013 Jun; 10(3):179-87. PubMed ID: 23802813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decade-long bacterial community dynamics in cystic fibrosis airways.
    Zhao J; Schloss PD; Kalikin LM; Carmody LA; Foster BK; Petrosino JF; Cavalcoli JD; VanDevanter DR; Murray S; Li JZ; Young VB; LiPuma JJ
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5809-14. PubMed ID: 22451929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
    Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ
    PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation.
    Quinn RA; Whiteson K; Lim YW; Salamon P; Bailey B; Mienardi S; Sanchez SE; Blake D; Conrad D; Rohwer F
    ISME J; 2015 Mar; 9(4):1024-38. PubMed ID: 25514533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
    Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
    Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
    Skolnik K; Nguyen A; Thornton CS; Waddell B; Williamson T; Rabin HR; Parkins MD
    BMC Infect Dis; 2017 Oct; 17(1):660. PubMed ID: 28969684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.